查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
生物打印：市场和机遇
市场调查报告书
商品编码
1134398

生物打印：市场和机遇

Bioprinting: Markets and Opportunities
出版日期: | 出版商: Additive Manufacturing Research | 英文 107 Pages | 订单完成后即时交付

价格
简介目录

目前，生物打印领域有100多家公司，其中大部分仅产生少量收入。

另一方面，生物打印的新应用领域正在迅速涌现，这非常符合医学的重要大趋势，特别是个性化医疗和“贴近患者”的趋势。例如，生物打印允许在诊所而不是专科医院进行皮肤移植等程序。

本报告分析了全球生物打印市场的趋势和机遇，包括市场的基本结构、主要驱动和製约因素、主要应用领域、技术概况和未来发展机会，以及相关技术（生物打印）、墨水等.) 主要公司的市场趋势、概况和业务战略，以及其他信息。

内容

第 1 章概述

  • 报告背景：生物打印的复兴？
  • 生物打印：极具吸引力的未来商机
    • 历史与展望
    • 生物打印行业的结构
    • 生物打印行业的演变
  • 公司的地域多样性
  • 本报告的目的、范围和计划
  • 本报告中使用的研究方法
  • 本章重点

第 2 章生物打印：市场驱动因素和挑战

  • 导致“生物打印时刻”的因素
  • 新型冠状病毒病 (COVID-19) 的影响因素：COVID-19 是生物打印市场的驱动因素
  • 人口老龄化：生物打印的作用
  • 生物打印和个性化医疗：让药物更贴近患者
  • 从之前的“生物打印时刻”中涌现出的新技术
    • 生物打印技术进步面临的挑战
  • 增加建模的可能性
  • 政府监管和资金的影响
  • 种类繁多的生物墨水
  • 生物打印的伦理问题
  • 本章重点

第 3 章生物打印机：技术和市场演变

  • 生物打印机的精髓
  • 挤压式生物打印机
    • 挤压式生物打印机示例
    • 挤压生物打印的未来
  • 喷墨生物打印机
    • 用于生物打印的热喷墨
    • 用于生物打印的压电喷墨
    • Rastrum Bioprinter：喷墨打印机示例
  • 立体光刻 (SLA)
    • 基于 SLA 的生物打印问题
    • SLA 生物打印机製造商
  • 其他生物打印技术
  • 生物打印机市场的未来预测（未来 10 年）：按技术和打印机类型
    • 从研究型生物打印到生物製造：未来预测
  • 本章重点

第 4 章生物墨水

  • 生物墨水简介
    • 支持/支持的生物打印
    • 水凝胶
    • 干细胞和生物打印
    • 球体和类器官
    • 陶瓷和生物打印
    • 剪切打印注意事项
  • 生物墨水的类型：按功能
    • 牺牲性生物墨水
    • 功能性生物墨水
    • 支持性生物墨水
  • 生物墨水材料
    • 琼脂糖
    • 海藻酸盐
    • 胶原蛋白
    • 明胶
    • 德国
    • 壳聚醣
    • 透明质酸
    • DECCM
    • 纤维蛋白
    • 纤维素
    • 丝绸
    • 基于细胞外基质 (ECM) 的生物墨水
    • 合成聚合物的作用
    • 智能生物墨水和具有先进材料添加剂的生物墨水
  • 逐步淘汰动物成分
  • Bioink 供应炼和供应商
  • 本章重点

第五章生物打印的主要应用领域

  • 生物打印应用领域分析：简介
  • 生物打印和改进的医学建模
    • 器官芯片
    • 疾病建模
  • 生物打印皮肤
    • 植皮背景
    • 生物打印和烧伤受害者
    • 用于皮肤生物打印的 Bioink
    • 化妆品检测
  • 骨/软骨打印
    • 用于骨骼/软骨打印的材料
  • 器官和血管的打印
    • 印刷和活体器官之间的竞争
    • 膀胱印
    • 生物打印和乳房植入物
    • 肝纹
    • 内分泌系统
    • 印刷胰腺
    • 肾臟生物打印
    • 肺
    • 耳朵和鼻子
    • 眼睛
    • 心臟和血管系统
    • 生物打印和神经组织
  • 生物打印在牙科应用中的注意事项
  • 本章重点

第 6 章生物打印的新方向

  • 简介
  • 软机器人
    • 使用生物材料的软机器人和打印
  • 食品印刷
    • 食品印刷的驱动力
    • 食品打印机和食品设计
    • 目前正在销售的食品打印机
    • 肉类生物打印
    • 糖果和巧克力印刷
    • 3D 打印主题餐厅
  • 平板印刷
    • 使用 3D 打印製造平板电脑：利弊
    • 增长的产业结构
  • 关于医疗设备的注意事项
  • 本章重点

第 7 章。9 家主要生物打印公司：概况和战略

  • 分析标准
  • 3DBio Therapeutics：面向医疗保健提供者的完整生物打印套件
  • 3D Systems/Systemic Bio：生物打印业务仍在摸索中
  • BICO (Cellink)：生物融合集团
  • Cyfuse：日本生物打印公司
  • EnvisionTEC/Desktop Metal：对生物打印的兴趣日益浓厚
  • FluidForm：利用尖端技术与大公司建立关係
  • Inventia 生命科学：脱离研发 (R&D)
  • Organovo Holdings：比以往更加专注
  • Rokit Healthcare：韩国生物打印和 Google Cloud

关于SmartTech分析

关于分析师

本报告中使用的首字母缩略词和缩略语

简介目录
Product Code: SMP-BIO2022-1022

SmarTech has been tracking the bioprinting industry for almost a decade and this is its third major bioprinting report. The report covers bioinks and bio-printing related applications, as well as well as the bioprinters themselves. Applications discussed in the report include drug discovery and testing, cosmetics testing, tissue and bone printing. We also examine the long-term prospects for transplanting bioprinted organs. And there is a chapter on new directions for bioprinting including discussions on soft robotics, pill printing, printed food.

The new SmarTech report provides a realistic assessment of bioprinting's commercial future including analysis of what the major bioprinting companies are designing their marketing strategies. In addition to the pure play bioprinting companies, the bioprinting sector is seeing involvement from major life science companies and 3D printing companies. There are now well over 100 firms in the bioprinting sector, but most of these companies have negligible revenues. Among the firms that are discussed in this report are 3DBio Therapeutics, 3D Systems/Systemic Bio, BICO (Cellink), Collplant, Cyfuse, EnvisionTEC/Desktop Metal, FluidForm, Inventia Life Science, Organovo Holdings, Poietis, Regamat, Rokit Healthcare and many others.

According to Lawrence Gasman , Founder of SmarTech Analysis and author of the report, "New applications are quickly emerging for bioprinting, and they are very much in line with important megatrends in healthcare-notably the trends towards personalized medicine and bringing care closer to the patient. For example, bioprinting can enable procedures such as skin grafting to be performed in a clinic rather than at specialized hospitals."

Table of Contents

Chapter One: Overview

  • 1.1. Background to Report: A Renaissance for Bioprinting?
  • 1.2. Bioprinting: An Attractive Business Opportunity Going Forward
    • 1.2.1. History and Prospects
    • 1.2.2. Bioprinting Industry Structure
    • 1.2.3. Evolution of the Bioprinting Industry
  • 1.3. Geographical Diversity of Companies
  • 1.4. Goal, Scope and Plan of this Report
  • 1.5. Methodology of this Report
    • 1.5.1. Forecasting Methodology and Assumptions
  • 1.6. Key Points from this Chapter

Chapter Two: Bioprinting: Market Drivers and Market Challenges

  • 2.1. Factors that Could Lead to the "Bioprinting Moment"
  • 2.2. The COVID Factor: COVID as a Bioprinting Market Driver
  • 2.3. The Aging Population: The Role of Bioprinting
  • 2.4. Bioprinting, Personalized Medicine and Bringing Healthcare Closer to the Patient
  • 2.5. New Technologies Emerge Since the Previous Bioprinting Moment
    • 2.5.1. Challenges to Technological Advances in Bioprinting
  • 2.6. The Growing Potential for Modeling
  • 2.7. Impact of Government Regulation and Funding
  • 2.8. A Broader Range of Bioinks
  • 2.9. Ethical Concerns with Bioprinting
  • 2.10. Key Points from this Chapter

Chapter Three: Bioprinters: Technical and Market Evolution

  • 3.1. The Essence of a Bioprinter
  • 3.2. Extrusion Bioprinters
    • 3.2.1. Examples of Extrusion Bioprinters
    • 3.2.2. The Future of Extrusion-based Bioprinting
  • 3.3. Inkjet Bioprinters
    • 3.3.1. Thermal Inkjet for Bioprinting
    • 3.3.2. Piezoelectric Inkjet for Bioprinting
    • 3.3.3. The Rastrum Bioprinter: An Example of an Inkjet Printer
  • 3.4. Stereolithography (SLA)
    • 3.4.1. The Problem with SLA-based Bioprinting
    • 3.4.2. Manufacturers of SLA Bioprinters
  • 3.5. Other Bioprinting Technologies
  • 3.6. Ten-year Forecasts of Bioprinter Markets by Printer Technology and Printer Type
    • 3.6.1. From Research Bioprinting to Biofabrication: A Forecast
  • 3.7. Key Points from this Chapter

Chapter Four: Bioinks

  • 4.1. Bioink Introductory
    • 4.1.1. Scaffold-based and Scaffold-free Bioprinting
    • 4.1.2. Hydrogels
    • 4.1.3. Stem Cells and Bioprinting
    • 4.1.4. Spheroids and Organoids
    • 4.1.5. Ceramics and Bioprinting
    • 4.1.6. A Note on Shear Printing
  • 4.2. Types of Bioinks: Functionality
    • 4.2.1. Sacrificial Bioinks
    • 4.2.2. Functional Bioinks
    • 4.2.3. Support Bioinks
  • 4.3. Materials for Bioinks
    • 4.3.1. Agarose
    • 4.3.2. Alginate
    • 4.3.3. Collagen
    • 4.3.4. Gelatin
    • 4.3.5. GelMA
    • 4.3.6. Chitosan
    • 4.3.7. Hyaluronic Acid
    • 4.3.8. dECM
    • 4.3.9. Fibrin
    • 4.3.10. Cellulose
    • 4.3.11. Silk
    • 4.3.12. Extracellular matrix (ECM)-based bioinks
    • 4.3.13. Role of Synthetic Polymers
    • 4.3.14. Smart Bioinks and Bioinks with Advanced Material Additives
  • 4.4. Phasing out Animal Materials
  • 4.5. Bioink Supply Chain and Suppliers
  • 4.6. Key Points from this Chapter

Chapter Five: Mainstream Bioprinting Applications

  • 5.1. Bioprinting Applications Analysis: Introductory
  • 5.2. Bioprinting and Improved Medical Modeling
    • 5.2.1. Organs-on-a-chip
    • 5.2.2. Disease Modeling
  • 5.3. Bioprinting Skin
    • 5.3.1. Background to Skin Grafting
    • 5.3.2. Bioprinting and Burn Victims
    • 5.3.3. Bioinks for Skin Bioprinting
    • 5.3.4. Cosmetics Testing
  • 5.4. Bone and Cartilage Printing
    • 5.4.1. Materials for Bone and Cartilage Printing
  • 5.5. Organ Printing and Vascular Printing
    • 5.5.1. Competition Between Printed Organs and Living Organs
    • 5.5.2. Bladder Printing
    • 5.5.3. Bioprinting and Breast Implants
    • 5.5.4. Liver Printing
    • 5.5.5. Endocrine System
    • 5.5.6. A Printed Pancreas
    • 5.5.7. Kidney Bioprinting
    • 5.5.8. Lungs
    • 5.5.9. Ears and Noses
    • 5.5.10. Eyes
    • 5.5.11. Hearts and Vasculature
    • 5.5.12. Bioprinting and Neural Tissue
  • 5.6. A Note on Dental Applications of Bioprinting
  • 5.7. Key Points from this Chapter

Chapter Six: New Directions in Bioprinting

  • 6.1. Introduction
  • 6.2. Soft Robotics
    • 6.2.1. Soft Robotics and Printing Using Biological Materials
  • 6.3. Food Printing
    • 6.3.1. Drivers for Food Printing
    • 6.3.2. Food Printers and Food Design
    • 6.3.3. Food Printers Currently Available
    • 6.3.4. Bioprinting Meat
    • 6.3.5. Printing Candies and Chocolates
    • 6.3.6. 3D Printing-Themed Restaurants
  • 6.4. Pill Printing
    • 6.4.1. Manufacturing of Pills Using 3D Printing: Advantages and Disadvantages
    • 6.4.2. Structure of a Growing Industry
  • 6.5. A Note on Medical Devices
  • 6.6. Key Points from this Report

Chapter Seven: Profiles of Nine Leading Bioprinting Firms and Their Strategies

  • 7.1. Criteria for Profiling
  • 7.2. 3DBio Therapeutics: Full Bioprinting Package for Healthcare Providers
  • 7.3. 3D Systems/Systemic Bio: Still Feeling its Way in the Bioprinting Business?
  • 7.4. BICO (Cellink): Bioconvergence Conglomerate
  • 7.5. Cyfuse - Japanese Bioprinting Firm
  • 7.6. EnvisionTEC/Desktop Metal: More Interest in Bioprinting
  • 7.7. FluidForm - Building Ties to Important Companies with Cutting Edge Technology
  • 7.8. Inventia Life Science: Breaking Out from R&D
  • 7.9. Organovo Holdings: More Focus Than Before
  • 7.10. Rokit Healthcare - Korean Bioprinting and Google Cloud

About SmarTech Analysis

About the Analyst

Acronyms and Abbreviations Used In this Report

List of Exhibits

  • Exhibit 1-1: Summary of the Bioprinting Market ($ Millions)
  • Exhibit 3-1: Bioprinter Markets by Class of Machine
  • Exhibit 3-2: Bioprinter Markets by Processing Technology
  • Exhibit 3-3: Bioprinter Markets by Role in Manufacturing Chain
  • Exhibit 4-1: Bioink Markets
  • Exhibit 5-1: Bioprinting Applications/Service Revenues ($ Millions)
  • Exhibit 6-1: Selected Food Printers